Hidden platform test and spatial probe trial results suggested that microglial SIRPα ablation accelerated cognitive impairment in AD mice at 5 months age, even preceding the plaque formation (Fig. 7d, e). This evidence concerns the gene SIRPA and Alzheimer disease.